Insights

Professional

Practice

Industry

Region

Firm News 43 results

Firm News | 3 min read | 04.01.24

Crowell Earns Top Rankings in Legal 500 EMEA 2024

Brussels and Doha – April 1, 2024: The Legal 500 Europe, Middle East & Africa (EMEA) 2024 edition has recognized 16 practice areas and 11 lawyers in Crowell & Moring’s Brussels and Doha offices. The 11 individual lawyers received 18 total rankings across the 16 different practice areas.

...

Firm News | 2 min read | 03.14.24

Chambers Ranks Crowell Lawyers and Practices in 2024 Europe Guide

Chambers and Partners has ranked five Crowell & Moring practice groups and seven individual lawyers in the Chambers Europe 2024 guide.

Firm News | 2 min read | 03.20.23

Chambers Ranks Six Crowell Lawyers and Four Practice Groups in 2023 Europe Guide

Brussels – March 20, 2023: Chambers and Partners has ranked four Crowell & Moring practice groups and six individual lawyers in the Chambers Europe 2023 guide. The rankings are driven by independent interviews of clients and members of the legal community.

...

Client Alerts 65 results

Client Alert | 6 min read | 10.23.24

Unfinished Business in Congress on Drug Patents and Competition

Before leaving for an extended recess period ahead of the November general election, Congress left unfinished several proposals with ramifications for generic and biosimilar drug competition. This client alert summarizes some of that legislation and possible next steps in the “lame duck” period before the end of the year.

...

Client Alert | 6 min read | 07.25.24

Preparing for the EU’s New Approach to Critical Medicines and Medicine Shortages: A New ‘Critical Medicines Act’?

The EU legal and policy framework regarding critical medicines and medicine shortages is rapidly changing. In the past 12 months alone, there have been numerous developments: from the ‘Non-Paper’; to the Communication on ‘Addressing medicine shortages’; and the launch of the Critical Medicines Alliance. In the next 12 months, there is likely to be similar developments – including a possible draft proposal for a ‘Critical Medicines Act’. As the new regulatory framework becomes clearer, pharma companies will need to understand it, and prepare for the impact it will have.

...

Client Alert | 7 min read | 07.24.24

Supercharge Patent Prosecution With Examiner Interviews

Examiner interviews are an optional but important and effective part of patent examination process that are beneficially conducted early and, in some cases, more than once during patent prosecution. Interviews are in-person, telephone or online conferences between the Examiner and the patent attorney or patent agent representing the patent applicant. When conducted early in the patent examination process, interviews may reduce the time required to obtain a patent and increase the odds of obtaining an allowance. As discussed below, interviews can help foster a cooperative interaction with the examiner to supercharge the prosecution process.

...

Press Coverage 9 results

Press Coverage | 03.28.23

Practitioners Mostly Agree Amgen Won’t Be A Sea Change, But Some Predict Grim Consequences

IPWatchdog

Press Coverage | 03.24.23

Amgen Supreme Court Arguments Aren't Just About Biology

Law360

Press Coverage | 09.08.22

The Name Game's Getting Harder—But This Lawyer's Helping Big Pharma In A Crowded Market

The National Law Journal

Publications 23 results

Publication | 02.24.23

Genus Claims Questions After Justices Deny Juno Rehearing

Law360

Publication | 09.13.22

How To Minimize Risk When Launching Smart Medical Devices

Law360

Publication | 04.05.22

Patentability Of Inventions Involving AI In Health Care Is Becoming A Key—And Complex—Issue

Law.com

Events 3 results

Event | 12.03.24, 8:30 AM EST - 9:30 AM EST

29th Annual Drug & Medical Device Litigation Conference

2024 has been a pivotal year for drug and medical device litigation, marked by significant case law developments that have reshape the landscape.

Event | 10.24.24, 5:30 PM EDT - 7:30 PM EDT

Do We Need a New Approach for Investing and Raising Funds in This Election Cycle?: A Fireside Chat and Networking Event for Emerging Companies and Investors

Join us for a networking event co-hosted by NYBIO and Crowell & Moring on October 24 between 5:30 and 7:30 pm. We will kick off the evening with a fireside chat moderated by Linda Malek, partner in the Healthcare and Privacy/Cybersecurity practices at Crowell in discussion with Andrew Lam, Managing Director and Head of Biotech Private Equity, Ally Bridge Group and Prem Premsrirut, Founder and CEO, Mirimus Inc. and Executive Director of Micoy Therapeutics.

Event | 03.09.23, 1:00 PM EST - 2:00 PM EST

Minimizing Risks When Launching Smart Medical Devices

More companies than ever before are launching smart medical devices and industry growth seems endless as new products and technologies are announced daily. However, before companies push products to market, it’s crucial to understand key aspects of device approval, and company and patient protection. In this webinar, our speakers will outline intellectual property strategies, U.S. Food and Drug Administration considerations, and data cybersecurity concerns that are inherent to all smart medical devices. They will explore the legal issues that can significantly decrease the risk profile and potential liabilities throughout a product's lifecycle and create safer, more reliable products for consumers.

...